nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A5—Rosuvastatin—atherosclerosis	0.0786	0.0939	CbGbCtD
Halofantrine—CYP3A5—Simvastatin—atherosclerosis	0.073	0.0873	CbGbCtD
Halofantrine—CYP3A5—Pravastatin—atherosclerosis	0.0715	0.0854	CbGbCtD
Halofantrine—CYP3A5—Lovastatin—atherosclerosis	0.0715	0.0854	CbGbCtD
Halofantrine—CYP2C8—Simvastatin—atherosclerosis	0.0702	0.0839	CbGbCtD
Halofantrine—CYP2C8—Lovastatin—atherosclerosis	0.0687	0.0821	CbGbCtD
Halofantrine—CYP2C8—Pravastatin—atherosclerosis	0.0687	0.0821	CbGbCtD
Halofantrine—CYP2D6—Niacin—atherosclerosis	0.0567	0.0677	CbGbCtD
Halofantrine—CYP2D6—Simvastatin—atherosclerosis	0.0448	0.0535	CbGbCtD
Halofantrine—CYP2D6—Lovastatin—atherosclerosis	0.0438	0.0524	CbGbCtD
Halofantrine—CYP2D6—Pravastatin—atherosclerosis	0.0438	0.0524	CbGbCtD
Halofantrine—CYP3A4—Ezetimibe—atherosclerosis	0.0306	0.0366	CbGbCtD
Halofantrine—CYP3A4—Rosuvastatin—atherosclerosis	0.0306	0.0366	CbGbCtD
Halofantrine—CYP3A4—Simvastatin—atherosclerosis	0.0285	0.034	CbGbCtD
Halofantrine—CYP3A4—Pravastatin—atherosclerosis	0.0279	0.0333	CbGbCtD
Halofantrine—CYP3A4—Lovastatin—atherosclerosis	0.0279	0.0333	CbGbCtD
Halofantrine—Sleep disorder—Rosuvastatin—atherosclerosis	0.00261	0.0169	CcSEcCtD
Halofantrine—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00212	0.0137	CcSEcCtD
Halofantrine—Sleep disorder—Simvastatin—atherosclerosis	0.00207	0.0134	CcSEcCtD
Halofantrine—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00199	0.0128	CcSEcCtD
Halofantrine—Abnormal vision—Niacin—atherosclerosis	0.00198	0.0128	CcSEcCtD
Halofantrine—Sleep disorder—Pravastatin—atherosclerosis	0.00187	0.0121	CcSEcCtD
Halofantrine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.0018	0.0116	CcSEcCtD
Halofantrine—Face oedema—Niacin—atherosclerosis	0.00159	0.0103	CcSEcCtD
Halofantrine—Orthostatic hypotension—Niacin—atherosclerosis	0.0015	0.00973	CcSEcCtD
Halofantrine—Abdominal distension—Niacin—atherosclerosis	0.00143	0.00927	CcSEcCtD
Halofantrine—Abdominal distension—Pravastatin—atherosclerosis	0.00141	0.00912	CcSEcCtD
Halofantrine—Arrhythmia—Rosuvastatin—atherosclerosis	0.0014	0.00904	CcSEcCtD
Halofantrine—Stomatitis—Niacin—atherosclerosis	0.00124	0.008	CcSEcCtD
Halofantrine—Chills—Lovastatin—atherosclerosis	0.00119	0.0077	CcSEcCtD
Halofantrine—Cough—Rosuvastatin—atherosclerosis	0.00119	0.00769	CcSEcCtD
Halofantrine—Myalgia—Rosuvastatin—atherosclerosis	0.00116	0.0075	CcSEcCtD
Halofantrine—Arthralgia—Rosuvastatin—atherosclerosis	0.00116	0.0075	CcSEcCtD
Halofantrine—Confusional state—Rosuvastatin—atherosclerosis	0.00112	0.00725	CcSEcCtD
Halofantrine—Back pain—Lovastatin—atherosclerosis	0.00112	0.00722	CcSEcCtD
Halofantrine—Chills—Simvastatin—atherosclerosis	0.00111	0.0072	CcSEcCtD
Halofantrine—Visual impairment—Niacin—atherosclerosis	0.0011	0.0071	CcSEcCtD
Halofantrine—Back pain—Ezetimibe—atherosclerosis	0.0011	0.00708	CcSEcCtD
Halofantrine—Visual impairment—Pravastatin—atherosclerosis	0.00108	0.00699	CcSEcCtD
Halofantrine—Ill-defined disorder—Lovastatin—atherosclerosis	0.00107	0.00693	CcSEcCtD
Halofantrine—Tinnitus—Niacin—atherosclerosis	0.00106	0.00687	CcSEcCtD
Halofantrine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00105	0.0068	CcSEcCtD
Halofantrine—Tinnitus—Pravastatin—atherosclerosis	0.00105	0.00676	CcSEcCtD
Halofantrine—Malaise—Lovastatin—atherosclerosis	0.00104	0.00673	CcSEcCtD
Halofantrine—Chills—Niacin—atherosclerosis	0.00102	0.00661	CcSEcCtD
Halofantrine—Malaise—Ezetimibe—atherosclerosis	0.00102	0.0066	CcSEcCtD
Halofantrine—Arrhythmia—Niacin—atherosclerosis	0.00102	0.00658	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00101	0.00655	CcSEcCtD
Halofantrine—Chills—Pravastatin—atherosclerosis	0.00101	0.00651	CcSEcCtD
Halofantrine—Ill-defined disorder—Simvastatin—atherosclerosis	0.001	0.00648	CcSEcCtD
Halofantrine—Arrhythmia—Pravastatin—atherosclerosis	0.001	0.00648	CcSEcCtD
Halofantrine—Palpitations—Ezetimibe—atherosclerosis	0.001	0.00647	CcSEcCtD
Halofantrine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000998	0.00646	CcSEcCtD
Halofantrine—Cough—Ezetimibe—atherosclerosis	0.000988	0.00639	CcSEcCtD
Halofantrine—Chest pain—Lovastatin—atherosclerosis	0.000983	0.00636	CcSEcCtD
Halofantrine—Myalgia—Lovastatin—atherosclerosis	0.000983	0.00636	CcSEcCtD
Halofantrine—Arthralgia—Lovastatin—atherosclerosis	0.000983	0.00636	CcSEcCtD
Halofantrine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000978	0.00633	CcSEcCtD
Halofantrine—Malaise—Simvastatin—atherosclerosis	0.000974	0.0063	CcSEcCtD
Halofantrine—Discomfort—Lovastatin—atherosclerosis	0.000971	0.00628	CcSEcCtD
Halofantrine—Arthralgia—Ezetimibe—atherosclerosis	0.000964	0.00624	CcSEcCtD
Halofantrine—Myalgia—Ezetimibe—atherosclerosis	0.000964	0.00624	CcSEcCtD
Halofantrine—Chest pain—Ezetimibe—atherosclerosis	0.000964	0.00624	CcSEcCtD
Halofantrine—Discomfort—Ezetimibe—atherosclerosis	0.000952	0.00616	CcSEcCtD
Halofantrine—Constipation—Rosuvastatin—atherosclerosis	0.000951	0.00615	CcSEcCtD
Halofantrine—Confusional state—Lovastatin—atherosclerosis	0.00095	0.00614	CcSEcCtD
Halofantrine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000942	0.00609	CcSEcCtD
Halofantrine—Confusional state—Ezetimibe—atherosclerosis	0.000932	0.00603	CcSEcCtD
Halofantrine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000924	0.00598	CcSEcCtD
Halofantrine—Chest pain—Simvastatin—atherosclerosis	0.000919	0.00595	CcSEcCtD
Halofantrine—Myalgia—Simvastatin—atherosclerosis	0.000919	0.00595	CcSEcCtD
Halofantrine—Arthralgia—Simvastatin—atherosclerosis	0.000919	0.00595	CcSEcCtD
Halofantrine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000916	0.00593	CcSEcCtD
Halofantrine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000909	0.00588	CcSEcCtD
Halofantrine—Discomfort—Simvastatin—atherosclerosis	0.000908	0.00587	CcSEcCtD
Halofantrine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000906	0.00586	CcSEcCtD
Halofantrine—Anorexia—Lovastatin—atherosclerosis	0.000898	0.00581	CcSEcCtD
Halofantrine—Confusional state—Simvastatin—atherosclerosis	0.000888	0.00575	CcSEcCtD
Halofantrine—Urticaria—Rosuvastatin—atherosclerosis	0.000883	0.00571	CcSEcCtD
Halofantrine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000881	0.0057	CcSEcCtD
Halofantrine—Malaise—Pravastatin—atherosclerosis	0.00088	0.00569	CcSEcCtD
Halofantrine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000879	0.00568	CcSEcCtD
Halofantrine—Palpitations—Niacin—atherosclerosis	0.000876	0.00567	CcSEcCtD
Halofantrine—Cough—Niacin—atherosclerosis	0.000865	0.0056	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000858	0.00555	CcSEcCtD
Halofantrine—Cough—Pravastatin—atherosclerosis	0.000852	0.00551	CcSEcCtD
Halofantrine—Paraesthesia—Lovastatin—atherosclerosis	0.000846	0.00547	CcSEcCtD
Halofantrine—Myalgia—Niacin—atherosclerosis	0.000844	0.00546	CcSEcCtD
Halofantrine—Arthralgia—Niacin—atherosclerosis	0.000844	0.00546	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000842	0.00545	CcSEcCtD
Halofantrine—Anorexia—Simvastatin—atherosclerosis	0.00084	0.00543	CcSEcCtD
Halofantrine—Myalgia—Pravastatin—atherosclerosis	0.000831	0.00538	CcSEcCtD
Halofantrine—Arthralgia—Pravastatin—atherosclerosis	0.000831	0.00538	CcSEcCtD
Halofantrine—Chest pain—Pravastatin—atherosclerosis	0.000831	0.00538	CcSEcCtD
Halofantrine—Paraesthesia—Ezetimibe—atherosclerosis	0.00083	0.00537	CcSEcCtD
Halofantrine—Dyspepsia—Lovastatin—atherosclerosis	0.000829	0.00536	CcSEcCtD
Halofantrine—Discomfort—Pravastatin—atherosclerosis	0.000821	0.00531	CcSEcCtD
Halofantrine—Decreased appetite—Lovastatin—atherosclerosis	0.000819	0.0053	CcSEcCtD
Halofantrine—Dyspepsia—Ezetimibe—atherosclerosis	0.000813	0.00526	CcSEcCtD
Halofantrine—Fatigue—Lovastatin—atherosclerosis	0.000812	0.00525	CcSEcCtD
Halofantrine—Anaphylactic shock—Niacin—atherosclerosis	0.000809	0.00523	CcSEcCtD
Halofantrine—Constipation—Lovastatin—atherosclerosis	0.000806	0.00521	CcSEcCtD
Halofantrine—Confusional state—Pravastatin—atherosclerosis	0.000803	0.0052	CcSEcCtD
Halofantrine—Decreased appetite—Ezetimibe—atherosclerosis	0.000803	0.0052	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000803	0.00519	CcSEcCtD
Halofantrine—Asthenia—Rosuvastatin—atherosclerosis	0.000798	0.00516	CcSEcCtD
Halofantrine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000797	0.00515	CcSEcCtD
Halofantrine—Fatigue—Ezetimibe—atherosclerosis	0.000797	0.00515	CcSEcCtD
Halofantrine—Paraesthesia—Simvastatin—atherosclerosis	0.000791	0.00512	CcSEcCtD
Halofantrine—Constipation—Ezetimibe—atherosclerosis	0.00079	0.00511	CcSEcCtD
Halofantrine—Pruritus—Rosuvastatin—atherosclerosis	0.000786	0.00509	CcSEcCtD
Halofantrine—Feeling abnormal—Lovastatin—atherosclerosis	0.000776	0.00502	CcSEcCtD
Halofantrine—Dyspepsia—Simvastatin—atherosclerosis	0.000776	0.00502	CcSEcCtD
Halofantrine—Anorexia—Niacin—atherosclerosis	0.000771	0.00499	CcSEcCtD
Halofantrine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00077	0.00498	CcSEcCtD
Halofantrine—Decreased appetite—Simvastatin—atherosclerosis	0.000766	0.00496	CcSEcCtD
Halofantrine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000761	0.00493	CcSEcCtD
Halofantrine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000761	0.00492	CcSEcCtD
Halofantrine—Fatigue—Simvastatin—atherosclerosis	0.00076	0.00491	CcSEcCtD
Halofantrine—Anorexia—Pravastatin—atherosclerosis	0.000759	0.00491	CcSEcCtD
Halofantrine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000756	0.00489	CcSEcCtD
Halofantrine—Constipation—Simvastatin—atherosclerosis	0.000753	0.00487	CcSEcCtD
Halofantrine—Urticaria—Lovastatin—atherosclerosis	0.000748	0.00484	CcSEcCtD
Halofantrine—Abdominal pain—Lovastatin—atherosclerosis	0.000745	0.00482	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000737	0.00477	CcSEcCtD
Halofantrine—Dizziness—Rosuvastatin—atherosclerosis	0.000735	0.00476	CcSEcCtD
Halofantrine—Urticaria—Ezetimibe—atherosclerosis	0.000734	0.00475	CcSEcCtD
Halofantrine—Abdominal pain—Ezetimibe—atherosclerosis	0.00073	0.00473	CcSEcCtD
Halofantrine—Paraesthesia—Niacin—atherosclerosis	0.000726	0.0047	CcSEcCtD
Halofantrine—Feeling abnormal—Simvastatin—atherosclerosis	0.000726	0.0047	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000726	0.0047	CcSEcCtD
Halofantrine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00072	0.00466	CcSEcCtD
Halofantrine—Paraesthesia—Pravastatin—atherosclerosis	0.000715	0.00463	CcSEcCtD
Halofantrine—Dyspepsia—Niacin—atherosclerosis	0.000712	0.00461	CcSEcCtD
Halofantrine—Decreased appetite—Niacin—atherosclerosis	0.000703	0.00455	CcSEcCtD
Halofantrine—Dyspepsia—Pravastatin—atherosclerosis	0.000701	0.00454	CcSEcCtD
Halofantrine—Rash—Rosuvastatin—atherosclerosis	0.000701	0.00453	CcSEcCtD
Halofantrine—Dermatitis—Rosuvastatin—atherosclerosis	0.0007	0.00453	CcSEcCtD
Halofantrine—Urticaria—Simvastatin—atherosclerosis	0.0007	0.00453	CcSEcCtD
Halofantrine—Abdominal pain—Simvastatin—atherosclerosis	0.000697	0.00451	CcSEcCtD
Halofantrine—Headache—Rosuvastatin—atherosclerosis	0.000696	0.0045	CcSEcCtD
Halofantrine—Decreased appetite—Pravastatin—atherosclerosis	0.000692	0.00448	CcSEcCtD
Halofantrine—Fatigue—Pravastatin—atherosclerosis	0.000687	0.00444	CcSEcCtD
Halofantrine—Constipation—Pravastatin—atherosclerosis	0.000681	0.00441	CcSEcCtD
Halofantrine—Asthenia—Lovastatin—atherosclerosis	0.000676	0.00437	CcSEcCtD
Halofantrine—Pruritus—Lovastatin—atherosclerosis	0.000666	0.00431	CcSEcCtD
Halofantrine—Asthenia—Ezetimibe—atherosclerosis	0.000663	0.00429	CcSEcCtD
Halofantrine—Gastrointestinal pain—Niacin—atherosclerosis	0.000662	0.00428	CcSEcCtD
Halofantrine—Nausea—Rosuvastatin—atherosclerosis	0.00066	0.00427	CcSEcCtD
Halofantrine—Feeling abnormal—Pravastatin—atherosclerosis	0.000656	0.00425	CcSEcCtD
Halofantrine—Pruritus—Ezetimibe—atherosclerosis	0.000654	0.00423	CcSEcCtD
Halofantrine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000651	0.00421	CcSEcCtD
Halofantrine—Diarrhoea—Lovastatin—atherosclerosis	0.000645	0.00417	CcSEcCtD
Halofantrine—Urticaria—Niacin—atherosclerosis	0.000643	0.00416	CcSEcCtD
Halofantrine—Abdominal pain—Niacin—atherosclerosis	0.00064	0.00414	CcSEcCtD
Halofantrine—Urticaria—Pravastatin—atherosclerosis	0.000633	0.00409	CcSEcCtD
Halofantrine—Asthenia—Simvastatin—atherosclerosis	0.000632	0.00409	CcSEcCtD
Halofantrine—Diarrhoea—Ezetimibe—atherosclerosis	0.000632	0.00409	CcSEcCtD
Halofantrine—Abdominal pain—Pravastatin—atherosclerosis	0.00063	0.00407	CcSEcCtD
Halofantrine—Pruritus—Simvastatin—atherosclerosis	0.000623	0.00403	CcSEcCtD
Halofantrine—Dizziness—Lovastatin—atherosclerosis	0.000623	0.00403	CcSEcCtD
Halofantrine—Dizziness—Ezetimibe—atherosclerosis	0.000611	0.00395	CcSEcCtD
Halofantrine—Diarrhoea—Simvastatin—atherosclerosis	0.000603	0.0039	CcSEcCtD
Halofantrine—Vomiting—Lovastatin—atherosclerosis	0.000599	0.00387	CcSEcCtD
Halofantrine—Rash—Lovastatin—atherosclerosis	0.000594	0.00384	CcSEcCtD
Halofantrine—Dermatitis—Lovastatin—atherosclerosis	0.000593	0.00384	CcSEcCtD
Halofantrine—Headache—Lovastatin—atherosclerosis	0.00059	0.00382	CcSEcCtD
Halofantrine—Vomiting—Ezetimibe—atherosclerosis	0.000587	0.0038	CcSEcCtD
Halofantrine—Dizziness—Simvastatin—atherosclerosis	0.000583	0.00377	CcSEcCtD
Halofantrine—Rash—Ezetimibe—atherosclerosis	0.000583	0.00377	CcSEcCtD
Halofantrine—Dermatitis—Ezetimibe—atherosclerosis	0.000582	0.00377	CcSEcCtD
Halofantrine—Asthenia—Niacin—atherosclerosis	0.00058	0.00376	CcSEcCtD
Halofantrine—Headache—Ezetimibe—atherosclerosis	0.000579	0.00374	CcSEcCtD
Halofantrine—Pruritus—Niacin—atherosclerosis	0.000572	0.0037	CcSEcCtD
Halofantrine—Asthenia—Pravastatin—atherosclerosis	0.000572	0.0037	CcSEcCtD
Halofantrine—Pruritus—Pravastatin—atherosclerosis	0.000564	0.00365	CcSEcCtD
Halofantrine—Vomiting—Simvastatin—atherosclerosis	0.00056	0.00362	CcSEcCtD
Halofantrine—Nausea—Lovastatin—atherosclerosis	0.00056	0.00362	CcSEcCtD
Halofantrine—Rash—Simvastatin—atherosclerosis	0.000556	0.00359	CcSEcCtD
Halofantrine—Dermatitis—Simvastatin—atherosclerosis	0.000555	0.00359	CcSEcCtD
Halofantrine—Diarrhoea—Niacin—atherosclerosis	0.000554	0.00358	CcSEcCtD
Halofantrine—Headache—Simvastatin—atherosclerosis	0.000552	0.00357	CcSEcCtD
Halofantrine—Nausea—Ezetimibe—atherosclerosis	0.000549	0.00355	CcSEcCtD
Halofantrine—Diarrhoea—Pravastatin—atherosclerosis	0.000545	0.00353	CcSEcCtD
Halofantrine—Dizziness—Niacin—atherosclerosis	0.000535	0.00346	CcSEcCtD
Halofantrine—Dizziness—Pravastatin—atherosclerosis	0.000527	0.00341	CcSEcCtD
Halofantrine—Nausea—Simvastatin—atherosclerosis	0.000523	0.00339	CcSEcCtD
Halofantrine—Vomiting—Niacin—atherosclerosis	0.000514	0.00333	CcSEcCtD
Halofantrine—Rash—Niacin—atherosclerosis	0.00051	0.0033	CcSEcCtD
Halofantrine—Dermatitis—Niacin—atherosclerosis	0.00051	0.0033	CcSEcCtD
Halofantrine—Headache—Niacin—atherosclerosis	0.000507	0.00328	CcSEcCtD
Halofantrine—Vomiting—Pravastatin—atherosclerosis	0.000506	0.00328	CcSEcCtD
Halofantrine—Rash—Pravastatin—atherosclerosis	0.000502	0.00325	CcSEcCtD
Halofantrine—Dermatitis—Pravastatin—atherosclerosis	0.000502	0.00325	CcSEcCtD
Halofantrine—Headache—Pravastatin—atherosclerosis	0.000499	0.00323	CcSEcCtD
Halofantrine—Nausea—Niacin—atherosclerosis	0.000481	0.00311	CcSEcCtD
Halofantrine—Nausea—Pravastatin—atherosclerosis	0.000473	0.00306	CcSEcCtD
Halofantrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	3.23e-05	0.00377	CbGpPWpGaD
Halofantrine—CYP2D6—Melatonin metabolism and effects—NFKB1—atherosclerosis	3.17e-05	0.0037	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—PRKCG—atherosclerosis	3.15e-05	0.00367	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	3.02e-05	0.00353	CbGpPWpGaD
Halofantrine—CYP2C8—Arachidonic acid metabolism—PTGS2—atherosclerosis	2.88e-05	0.00335	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	2.87e-05	0.00335	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	2.84e-05	0.00331	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	2.75e-05	0.00321	CbGpPWpGaD
Halofantrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	2.67e-05	0.00312	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	2.57e-05	0.00299	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	2.47e-05	0.00288	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	2.47e-05	0.00287	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	2.47e-05	0.00287	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	2.44e-05	0.00284	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	2.33e-05	0.00272	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	2.28e-05	0.00266	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	2.25e-05	0.00262	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—GSTM1—atherosclerosis	2.19e-05	0.00256	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—GSTM1—atherosclerosis	2.16e-05	0.00252	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—TNF—atherosclerosis	2e-05	0.00233	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	1.95e-05	0.00227	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—GSTM1—atherosclerosis	1.9e-05	0.00221	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—GSTM1—atherosclerosis	1.87e-05	0.00218	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	1.83e-05	0.00214	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	1.83e-05	0.00214	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	1.8e-05	0.0021	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	1.77e-05	0.00206	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	1.63e-05	0.0019	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—IL6—atherosclerosis	1.61e-05	0.00188	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	1.56e-05	0.00182	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LDLRAP1—atherosclerosis	1.55e-05	0.00181	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	1.55e-05	0.0018	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	1.55e-05	0.0018	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	1.55e-05	0.0018	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	1.55e-05	0.0018	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	1.54e-05	0.00179	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	1.53e-05	0.00178	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	1.48e-05	0.00172	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PLTP—atherosclerosis	1.46e-05	0.0017	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	1.42e-05	0.00165	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	1.36e-05	0.00159	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LDLRAP1—atherosclerosis	1.35e-05	0.00157	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.32e-05	0.00153	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCG8—atherosclerosis	1.27e-05	0.00148	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LTA4H—atherosclerosis	1.27e-05	0.00148	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PLTP—atherosclerosis	1.27e-05	0.00148	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.17e-05	0.00137	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.17e-05	0.00136	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.16e-05	0.00135	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.13e-05	0.00132	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	1.11e-05	0.00129	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LTA4H—atherosclerosis	1.1e-05	0.00128	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCG8—atherosclerosis	1.1e-05	0.00128	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.08e-05	0.00126	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PLTP—atherosclerosis	1.04e-05	0.00121	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.02e-05	0.00119	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.02e-05	0.00119	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.01e-05	0.00117	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCG1—atherosclerosis	1e-05	0.00117	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—FABP4—atherosclerosis	9.42e-06	0.0011	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LCAT—atherosclerosis	9.42e-06	0.0011	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOA4—atherosclerosis	9.25e-06	0.00108	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	9.12e-06	0.00106	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP7A1—atherosclerosis	9.08e-06	0.00106	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LTA4H—atherosclerosis	9.01e-06	0.00105	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCG8—atherosclerosis	9.01e-06	0.00105	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCG1—atherosclerosis	8.68e-06	0.00101	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP27A1—atherosclerosis	8.4e-06	0.000979	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—FABP4—atherosclerosis	8.16e-06	0.000951	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LCAT—atherosclerosis	8.16e-06	0.000951	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOA4—atherosclerosis	8.01e-06	0.000934	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	7.96e-06	0.000928	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALOX15—atherosclerosis	7.96e-06	0.000928	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	7.96e-06	0.000928	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOA2—atherosclerosis	7.96e-06	0.000928	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP7A1—atherosclerosis	7.87e-06	0.000917	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCG5—atherosclerosis	7.86e-06	0.000917	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LPA—atherosclerosis	7.59e-06	0.000885	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.5e-06	0.000874	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—BGN—atherosclerosis	7.35e-06	0.000857	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOA5—atherosclerosis	7.28e-06	0.000849	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP27A1—atherosclerosis	7.27e-06	0.000848	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	7.23e-06	0.000843	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.16e-06	0.000835	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCG1—atherosclerosis	7.13e-06	0.000831	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	7.01e-06	0.000817	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.99e-06	0.000814	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALOX15—atherosclerosis	6.89e-06	0.000804	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	6.89e-06	0.000804	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOA2—atherosclerosis	6.89e-06	0.000804	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	6.89e-06	0.000804	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCG5—atherosclerosis	6.81e-06	0.000794	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.8e-06	0.000793	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PLTP—atherosclerosis	6.8e-06	0.000792	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALOX5—atherosclerosis	6.77e-06	0.000789	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—FABP4—atherosclerosis	6.7e-06	0.000781	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LCAT—atherosclerosis	6.7e-06	0.000781	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LPA—atherosclerosis	6.58e-06	0.000767	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOA4—atherosclerosis	6.58e-06	0.000767	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	6.46e-06	0.000753	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—BGN—atherosclerosis	6.37e-06	0.000743	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.32e-06	0.000737	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOA5—atherosclerosis	6.31e-06	0.000735	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.13e-06	0.000714	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NAMPT—atherosclerosis	6.07e-06	0.000708	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	6.07e-06	0.000708	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LIPC—atherosclerosis	6.03e-06	0.000703	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6e-06	0.0007	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOC3—atherosclerosis	6e-06	0.000699	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	5.97e-06	0.000696	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LDLR—atherosclerosis	5.96e-06	0.000695	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.95e-06	0.000693	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.93e-06	0.000692	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCG8—atherosclerosis	5.89e-06	0.000687	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LTA4H—atherosclerosis	5.89e-06	0.000687	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALOX5—atherosclerosis	5.86e-06	0.000683	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CETP—atherosclerosis	5.82e-06	0.000679	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	5.66e-06	0.00066	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALOX15—atherosclerosis	5.66e-06	0.00066	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOA2—atherosclerosis	5.66e-06	0.00066	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	5.66e-06	0.00066	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCG5—atherosclerosis	5.59e-06	0.000652	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SCARB1—atherosclerosis	5.57e-06	0.00065	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.42e-06	0.000631	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LPA—atherosclerosis	5.4e-06	0.00063	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HMGCR—atherosclerosis	5.26e-06	0.000614	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NAMPT—atherosclerosis	5.26e-06	0.000613	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—BGN—atherosclerosis	5.23e-06	0.00061	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.23e-06	0.000609	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LIPC—atherosclerosis	5.23e-06	0.000609	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOC3—atherosclerosis	5.19e-06	0.000605	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOA5—atherosclerosis	5.18e-06	0.000604	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LDLR—atherosclerosis	5.16e-06	0.000602	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CETP—atherosclerosis	5.04e-06	0.000588	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	4.98e-06	0.000581	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SCARB1—atherosclerosis	4.83e-06	0.000563	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALOX5—atherosclerosis	4.81e-06	0.000561	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.7e-06	0.000548	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ABCA1—atherosclerosis	4.69e-06	0.000547	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.66e-06	0.000543	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HMGCR—atherosclerosis	4.56e-06	0.000532	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—FABP4—atherosclerosis	4.38e-06	0.000511	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LCAT—atherosclerosis	4.38e-06	0.000511	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NAMPT—atherosclerosis	4.32e-06	0.000503	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOA4—atherosclerosis	4.3e-06	0.000501	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LIPC—atherosclerosis	4.29e-06	0.0005	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOC3—atherosclerosis	4.26e-06	0.000497	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LDLR—atherosclerosis	4.24e-06	0.000494	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4.22e-06	0.000492	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CETP—atherosclerosis	4.14e-06	0.000483	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.11e-06	0.000479	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ABCA1—atherosclerosis	4.06e-06	0.000474	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HMOX1—atherosclerosis	4.03e-06	0.000469	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SCARB1—atherosclerosis	3.96e-06	0.000462	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.9e-06	0.000455	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOB—atherosclerosis	3.86e-06	0.000449	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GSTM1—atherosclerosis	3.75e-06	0.000437	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HMGCR—atherosclerosis	3.74e-06	0.000436	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.7e-06	0.000431	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.7e-06	0.000431	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.7e-06	0.000431	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOA2—atherosclerosis	3.7e-06	0.000431	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LPL—atherosclerosis	3.68e-06	0.000429	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.66e-06	0.000426	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GPX1—atherosclerosis	3.59e-06	0.000419	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LPA—atherosclerosis	3.53e-06	0.000412	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CD36—atherosclerosis	3.5e-06	0.000408	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.49e-06	0.000406	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—BGN—atherosclerosis	3.42e-06	0.000399	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOA5—atherosclerosis	3.38e-06	0.000395	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOB—atherosclerosis	3.34e-06	0.000389	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ABCA1—atherosclerosis	3.34e-06	0.000389	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTHFR—atherosclerosis	3.31e-06	0.000386	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.26e-06	0.00038	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARA—atherosclerosis	3.25e-06	0.000379	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GSTM1—atherosclerosis	3.25e-06	0.000379	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LPL—atherosclerosis	3.19e-06	0.000372	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AGT—atherosclerosis	3.15e-06	0.000367	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.15e-06	0.000367	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GPX1—atherosclerosis	3.11e-06	0.000363	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOE—atherosclerosis	3.09e-06	0.00036	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CAV1—atherosclerosis	3.06e-06	0.000356	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—APOA1—atherosclerosis	3.05e-06	0.000356	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CD36—atherosclerosis	3.03e-06	0.000353	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.87e-06	0.000335	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HMOX1—atherosclerosis	2.86e-06	0.000334	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.82e-06	0.000329	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARA—atherosclerosis	2.82e-06	0.000328	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LIPC—atherosclerosis	2.8e-06	0.000327	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOC3—atherosclerosis	2.79e-06	0.000325	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	2.78e-06	0.000325	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LDLR—atherosclerosis	2.77e-06	0.000323	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOB—atherosclerosis	2.74e-06	0.00032	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AGT—atherosclerosis	2.73e-06	0.000318	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CETP—atherosclerosis	2.71e-06	0.000315	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARG—atherosclerosis	2.69e-06	0.000313	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOE—atherosclerosis	2.67e-06	0.000312	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GSTM1—atherosclerosis	2.67e-06	0.000311	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CAV1—atherosclerosis	2.65e-06	0.000309	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—APOA1—atherosclerosis	2.64e-06	0.000308	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—INS—atherosclerosis	2.64e-06	0.000307	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LPL—atherosclerosis	2.62e-06	0.000305	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.59e-06	0.000302	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GPX1—atherosclerosis	2.55e-06	0.000298	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CD36—atherosclerosis	2.49e-06	0.00029	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.45e-06	0.000285	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ALB—atherosclerosis	2.42e-06	0.000282	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.41e-06	0.000281	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTHFR—atherosclerosis	2.36e-06	0.000275	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARG—atherosclerosis	2.33e-06	0.000271	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARA—atherosclerosis	2.31e-06	0.00027	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NOS3—atherosclerosis	2.31e-06	0.00027	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—INS—atherosclerosis	2.28e-06	0.000266	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AGT—atherosclerosis	2.24e-06	0.000261	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOE—atherosclerosis	2.19e-06	0.000256	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.18e-06	0.000254	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CAV1—atherosclerosis	2.17e-06	0.000253	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—APOA1—atherosclerosis	2.17e-06	0.000253	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.11e-06	0.000247	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ALB—atherosclerosis	2.09e-06	0.000244	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NOS3—atherosclerosis	2e-06	0.000233	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.98e-06	0.000231	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARG—atherosclerosis	1.91e-06	0.000223	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—INS—atherosclerosis	1.87e-06	0.000219	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.87e-06	0.000218	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.83e-06	0.000214	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOB—atherosclerosis	1.79e-06	0.000209	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.74e-06	0.000203	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ALB—atherosclerosis	1.72e-06	0.0002	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LPL—atherosclerosis	1.71e-06	0.0002	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GPX1—atherosclerosis	1.67e-06	0.000195	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NOS3—atherosclerosis	1.64e-06	0.000192	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CD36—atherosclerosis	1.63e-06	0.00019	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.54e-06	0.00018	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARA—atherosclerosis	1.51e-06	0.000176	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.5e-06	0.000175	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AGT—atherosclerosis	1.46e-06	0.000171	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOE—atherosclerosis	1.43e-06	0.000167	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.42e-06	0.000166	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.42e-06	0.000165	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.29e-06	0.000151	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.25e-06	0.000146	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—INS—atherosclerosis	1.23e-06	0.000143	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ALB—atherosclerosis	1.12e-06	0.000131	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.07e-06	0.000125	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKT1—atherosclerosis	1.06e-06	0.000124	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PTGS2—atherosclerosis	9.83e-07	0.000115	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKT1—atherosclerosis	9.2e-07	0.000107	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKT1—atherosclerosis	7.56e-07	8.81e-05	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKT1—atherosclerosis	4.94e-07	5.76e-05	CbGpPWpGaD
